Amazon-Brand Acetaminophen Recall: 112,932 Bottles Pulled Nationwide Over Discolored Pills
Aurobindo Pharma recalls 112,932 bottles of Amazon-brand acetaminophen after consumer complaints of discolored tablets. FDA has not yet classified the recall.
From the latest clinical research and public health alerts to nutrition advice and mental health insights, get reliable health information to make informed decisions for yourself and your family.
Aurobindo Pharma recalls 112,932 bottles of Amazon-brand acetaminophen after consumer complaints of discolored tablets. FDA has not yet classified the recall.
Retatrutide shines in phase 3 trial, cutting weight 18.8% in diabetes patients. But two deaths from bootleg versions raise red flags about illicit use.
Flu cases are rising earlier than usual in England, with hospital admissions at record highs for this time of year. NHS urges at-risk groups to get vaccinated.
UKHSA data shows flu activity rose in September, higher than in four previous winters. Health officials urge vaccination as NHS faces early winter pressure.
Millions of seniors received $90 Social Security deposits this week as part of a Trump administration Medicare rebate. Here's who qualifies and why 40 million d
Danielle Quinn, the Glasgow influencer who documented her Stage 3 cancer journey, has died at 41, days after announcing she was receiving end-of-life care.
UK Covid cases more than doubled in September as the XFG 'Stratus' variant spreads. Hospital admissions jumped over 400% in a month, UKHSA data shows.
Cardiologists debunk cholesterol myths as misinformation spreads online, warning that high LDL remains a major heart risk and statins save lives.
Trump sends $90 Medicare Part B payments to 20 million seniors from a $2B fund, while HMSA cuts Medicare Advantage plans affecting 16,000 in Hawaii.
The XFG 'American Covid' strain is behind a 50% rise in England hospital admissions. Experts say cases remain low and vaccines target the variant.
Trump starts mailing $500 ACA refund checks to nearly 1 million enrollees in 30 states, five weeks before midterm elections.
New phase 3 trials show retatrutide, a triple-agonist drug, helped patients lose up to 25% of body weight and aided diabetes, knee arthritis, and sleep apnea.